A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products

NCT ID: NCT02517541

Last Updated: 2022-11-16

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to obtain an understanding of relevant parameters affecting the performance of ostomy products.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

72 subjects will be included. Each subject will attend 3 visits at the clinic/hospital or at the subjects home depending on the final site set-up. Each subject will be enrolled for 14 weeks in total for the entire investigation.

Coloplast will provide SenSura Mio Convex Soft for all subjects via the investigator. Based on the subjects' usual changing pattern, the investigator will provide the subjects with enough products for the whole test period.

The subject will answer questions regarding the tested products by filling out the subject part in the eCRF daily. The subject will answer questions using an electronic device and use the device to take pictures of the peristomal skin and used products at each product change. The Investigator fills out the investigator part of the eCRF at each visit. The subjects must complete the general questions at the end of each test period before their second and third visit at the Clinic/hospital or at home to avoid influence by the investigator.

The use of accessories will be noted in the eCRF. Samples of biological material will not be taken or used in this investigation. Patient files from own physician will not be used for subjects recruited via a Coloplast's database. The investigators may use patient files for subjects recruited via hospital sites/ostomy clinics to identifying relevant subjects and/or to verify baseline information, concomitant medication or adverse events. To be able to fulfil the objectives, the investigation must include both ileostomists and colostomists.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ileostomy - Stoma Colostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test period

The arm consists of a two-week baseline period where subjects apply their own product and a 12 weeks test period where the subjects apply the intervention (SenSura Mio Convex Soft)

Group Type EXPERIMENTAL

SenSura Mio Convex Soft

Intervention Type DEVICE

SenSura Mio Convex Soft is a CE marked ostomy product manufactured by Coloplast

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SenSura Mio Convex Soft

SenSura Mio Convex Soft is a CE marked ostomy product manufactured by Coloplast

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have given written informed consent
* Be at least 18 years of age and have full legal capacity
* Have an ileostomy or colostomy
* Have had their ostomy for at least 3 months
* Must use 1 piece open or closed ostomy products during the test period
* Currently using a 1 piece. flat product
* Must be able to use custom cut product
* Have intact peristomal skin
* Has experienced leakage (seeping) under the baseplate at least three times during the last two weeks
* Are evaluated to be suitable for a soft convex product

Exclusion Criteria

* Currently receiving or have within the past 2 month received radio- and/or chemotherapy
* Currently or having within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
* Are pregnant or breastfeeding
* Participating in other interventional clinical investigations or have previously participated in this investigation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Camilla F Vibjerg, M.Sc.pharm

Role: STUDY_CHAIR

Head of Clinical Operations

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Chicago Medicine

Chicago, Illinois, United States

Site Status

Prism research center

Saint Paul, Minnesota, United States

Site Status

QPS Netherlands

Groningen, , Netherlands

Site Status

Helse Nordbyen

Larvik, , Norway

Site Status

Synexus Midlands

Birmingham, , United Kingdom

Site Status

Pilgrim Hospital

Boston, , United Kingdom

Site Status

Cheltenham General Hospital

Cheltenham, , United Kingdom

Site Status

Kettering General hospital

Kettering, , United Kingdom

Site Status

Lincon Country hospital

Lincoln, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Netherlands Norway United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP259

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

An Investigation of Ostomy Devices
NCT01514136 COMPLETED NA
Feasibility of a Newly Developed Ostomy Prototype
NCT07146035 NOT_YET_RECRUITING NA
Ostomy Readmission Reduction Program
NCT06956274 NOT_YET_RECRUITING